MEMORIAL DAY OFFER 50% OFF Premium Subscription Order Now MEMORIAL DAY 50% OFF Subscription >>

No Pain, No Gain.Week 21 On Stock Market Click to watch.

Auris Medical Holding AG Stock Forecast

NASDAQ:EARS BUY SELL

$0.75 (-0.13%)

Volume: 0

Closed: May 27, 2022

Hollow Logo Score: 0.000

Auris Medical Holding AG Stock Forecast

BUY SELL NASDAQ:EARS
$0.75 (-0.13%)

Volume: 0

Closed: May 27, 2022

Score Hollow Logo 0.000

EARS Stock Trend

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.56 is broken, it will firstly indicate a stronger fall rate.

Given the current short-term trend, the stock is expected to fall -8.85% during the next 3 months and, with a 90% probability hold a price between $0.51 and $1.46 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-06-01 $0.55 $1.07 $1.60
2022-06-02 $0.55 $1.07 $1.59
2022-06-03 $0.55 $1.07 $1.59
2022-06-06 $0.55 $1.07 $1.59
2022-06-07 $0.54 $1.06 $1.59
2022-06-08 $0.54 $1.06 $1.58
2022-06-09 $0.54 $1.06 $1.58
2022-06-10 $0.54 $1.06 $1.58
2022-06-13 $0.53 $1.05 $1.58
2022-06-14 $0.53 $1.05 $1.57
2022-06-15 $0.53 $1.05 $1.57
2022-06-16 $0.53 $1.05 $1.57
2022-06-17 $0.52 $1.04 $1.57
2022-06-21 $0.52 $1.04 $1.56
2022-06-22 $0.52 $1.04 $1.56
2022-06-23 $0.52 $1.04 $1.56
2022-06-24 $0.51 $1.04 $1.56
2022-06-27 $0.51 $1.03 $1.55
2022-06-28 $0.51 $1.03 $1.55
2022-06-29 $0.51 $1.03 $1.55
2022-06-30 $0.50 $1.03 $1.55
2022-07-01 $0.50 $1.02 $1.54
2022-07-05 $0.50 $1.02 $1.54
2022-07-06 $0.50 $1.02 $1.54
2022-07-07 $0.49 $1.02 $1.54
2022-07-08 $0.49 $1.01 $1.53
2022-07-11 $0.49 $1.01 $1.53
2022-07-12 $0.49 $1.01 $1.53
2022-07-13 $0.48 $1.01 $1.53
2022-07-14 $0.48 $1.00 $1.52

About Auris Medical Holding AG

Auris Medical Holding AG Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical development for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss; and other pre-clinical stage products comprising AM-102 and AM-123. It has... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT